1-4 of 4
Claire L. Green
Close
Sort by
Journal Articles

The Use of DNA Methylation Profiling to Assess the Significance of Different Types of Mutations in CEBPA -Mutated AML

Dima El-Sharkawi, MBBS, Claire L Green, PhD, Duncan Sproul, PhD, Sarah Jenkinson, MSc, Andrew Feber, PhD, David C Linch, FMedSci, Rosemary E Gale
Journal: Blood
Blood (2014) 124 (21): 2328.
https://doi.org/10.1182/blood.V124.21.2328.2328
Published: 2014
Journal Articles

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation

Brief Report
Claire L. Green, Catherine M. Evans, Lu Zhao, Robert K. Hills, Alan K. Burnett, David C. Linch, Rosemary E. Gale
Journal: Blood
Blood (2011) 118 (2): 409–412.
https://doi.org/10.1182/blood-2010-12-322479
Published: 2011
Includes: Supplemental data
Journal Articles

Younger Adult Acute Myeloid Leukemia (AML) Patients with IDH2-R140 Mutations Have a Significantly Better Prognosis Than Those with Either IDH2-R172 or IDH1 Mutations

Claire L Green, Catherine M Evans, Robert Hills, MA, MSc, DPhil, Lu Zhao, Alan Burnett, David C Linch, MD, Rosemary Gale, PhD
Journal: Blood
Blood (2010) 116 (21): 100.
https://doi.org/10.1182/blood.V116.21.100.100
Published: 2010
Journal Articles

The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3 /ITD status

Brief Report
Claire L. Green, Catherine M. Evans, Robert K. Hills, Alan K. Burnett, David C. Linch, Rosemary E. Gale
Journal: Blood
Blood (2010) 116 (15): 2779–2782.
https://doi.org/10.1182/blood-2010-02-270926
Published: 2010
Includes: Supplemental data